Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVTA | Buy | InVitae Corporation | $3,140,000 | +10.0% | 1,276,541 | +9.1% | 2.19% | +9.1% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EQRx, Inc. | $81,786,000 | – | 17,438,465 | – | 57.43% | – | |
| NAUT | New | Nautilus Biotechnology, Inc. | $43,842,000 | – | 16,298,006 | – | 30.79% | – |
| New | Erasca, Inc. | $13,925,000 | – | 2,500,000 | – | 9.78% | – | |
| NVTA | New | InVitae Corporation | $2,855,000 | – | 1,170,127 | – | 2.00% | – |